BTC $64,791.49 +1.22%
ETH $1,919.75 +1.29%
BNB $592.01 +4.30%
XRP $1.08 +1.80%
SOL $74.64 +2.28%
TRX $0.3292 +0.98%
DOGE $0.0704 +0.55%
ADA $0.1719 +5.53%
BCH $221.06 +5.45%
LINK $8.48 +2.62%
HYPE $54.54 -0.28%
AAVE $99.71 +1.57%
SUI $0.7008 +2.57%
XLM $0.1726 +0.47%
ZEC $474.49 +2.56%
BTC $64,791.49 +1.22%
ETH $1,919.75 +1.29%
BNB $592.01 +4.30%
XRP $1.08 +1.80%
SOL $74.64 +2.28%
TRX $0.3292 +0.98%
DOGE $0.0704 +0.55%
ADA $0.1719 +5.53%
BCH $221.06 +5.45%
LINK $8.48 +2.62%
HYPE $54.54 -0.28%
AAVE $99.71 +1.57%
SUI $0.7008 +2.57%
XLM $0.1726 +0.47%
ZEC $474.49 +2.56%

US stock MEIP rose over 33% today, with a market value reaching 41.24 million USD

2025-07-19 00:18:45
Collection

ChainCatcher news, according to market news, MEI Pharma (NASDAQ: MEIP) rose over 33% today, with a market capitalization reaching $41.2431 million.

Previously, it was reported that Titan Partners Group and crypto investment firm GSR are jointly leading a strategic transformation for the American pharmaceutical company MEI Pharma (NASDAQ: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, over $100 million in funding commitments have been made for this project. Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

app_icon
ChainCatcher Building the Web3 world with innovations.